0.6576
price down icon1.13%   -0.0075
after-market After Hours: .64 -0.0176 -2.68%
loading

Lyell Immunopharma Inc Stock (LYEL) Latest News

pulisher
Feb 20, 2025

Lyell Immunopharma (LYEL) Projected to Post Earnings on Wednesday - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences - GlobeNewswire

Feb 19, 2025
pulisher
Feb 18, 2025

LYELLyell Immunopharma, Inc. Latest Stock News & Market Updates - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

Cell Therapy Pioneer Lyell to Showcase Cancer Treatment Breakthroughs at Elite Investor Events - StockTitan

Feb 18, 2025
pulisher
Feb 18, 2025

What Did We Find About Insider Trading At Lyell Immunopharma Inc (NASDAQ: LYEL)? - Stocks Register

Feb 18, 2025
pulisher
Feb 17, 2025

Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Following a 67% decline over last year, recent gains may please Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners - Simply Wall St

Feb 17, 2025
pulisher
Feb 14, 2025

SG Americas Securities LLC Has $75,000 Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Feb 14, 2025
pulisher
Feb 10, 2025

Market Recap Check: Lyell Immunopharma Inc (LYEL)’s Negative Finish at 0.57, Up/Down -2.94 - The Dwinnex

Feb 10, 2025
pulisher
Feb 07, 2025

Lyell Immunopharma Inc (LYEL) Stock: A Year of Market Fluctuations - The InvestChronicle

Feb 07, 2025
pulisher
Feb 06, 2025

Take off with Lyell Immunopharma Inc (LYEL): Get ready for trading - SETE News

Feb 06, 2025
pulisher
Feb 04, 2025

LYEL underperforms with a -0.98 decrease in share price - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Market Momentum Report: Lyell Immunopharma Inc (LYEL)’s Negative Close at 0.58 - The Dwinnex

Feb 04, 2025
pulisher
Jan 31, 2025

Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 46% stake - Yahoo Finance

Jan 31, 2025
pulisher
Jan 25, 2025

Lyell Immunopharma Faces Nasdaq delisting over share price - MSN

Jan 25, 2025
pulisher
Jan 25, 2025

Lyell Immunopharma Faces Nasdaq delisting over share price By Investing.com - Investing.com Australia

Jan 25, 2025
pulisher
Jan 20, 2025

Barclays PLC Has $332,000 Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Jan 20, 2025
pulisher
Jan 13, 2025

Lyell Immunopharma price target lowered to 60c from $1 at BofA - MSN

Jan 13, 2025
pulisher
Jan 13, 2025

Lyell Immunopharma stock hits 52-week low at $0.58 - Investing.com India

Jan 13, 2025
pulisher
Jan 09, 2025

Lyell to Highlight Vision for its Next-Generation CAR - GlobeNewswire

Jan 09, 2025
pulisher
Jan 09, 2025

Lyell's IMPT-314 Cancer Therapy Shows 94% Response Rate, Plans Pivotal Trials for Lymphoma - StockTitan

Jan 09, 2025
pulisher
Jan 08, 2025

Jane Street Group LLC Buys 111,917 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Jan 08, 2025
pulisher
Jan 05, 2025

Barclays PLC Has $332,000 Stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Jan 05, 2025
pulisher
Dec 31, 2024

After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL) - Yahoo Finance

Dec 31, 2024
pulisher
Dec 30, 2024

After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL) - Yahoo Finance

Dec 30, 2024
pulisher
Dec 30, 2024

State Street Corp Has $5.37 Million Stock Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Dec 30, 2024
pulisher
Dec 22, 2024

Cellares and Lyell to Evaluate Automated Manufacturing of Lyell' - GuruFocus.com

Dec 22, 2024
pulisher
Dec 17, 2024

Charles Schwab Investment Management Inc. Trims Stock Holdings in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Shares Sold by Fmr LLC - Defense World

Dec 16, 2024
pulisher
Dec 16, 2024

Fmr LLC Has $1.41 Million Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - MarketBeat

Dec 16, 2024
pulisher
Dec 13, 2024

Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround - Yahoo Finance

Dec 13, 2024
pulisher
Dec 12, 2024

Lyell Immunopharma stock hits 52-week low at $0.85 By Investing.com - Investing.com Australia

Dec 12, 2024
pulisher
Dec 11, 2024

Lyell Immunopharma stock hits 52-week low at $0.85 - Investing.com India

Dec 11, 2024
pulisher
Dec 10, 2024

Lyell's IMPT-314 Cancer Therapy Shows Stunning 94% Response Rate in Lymphoma Trial - StockTitan

Dec 10, 2024
pulisher
Dec 09, 2024

Lyell Presents Positive Initial Clinical Data from the - GlobeNewswire

Dec 09, 2024
pulisher
Dec 09, 2024

Form 424B5 Lyell Immunopharma, Inc. - StreetInsider.com

Dec 09, 2024
pulisher
Dec 09, 2024

Intech Investment Management LLC Acquires New Shares in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Dec 09, 2024
pulisher
Nov 29, 2024

SEC Form S-3 filed by Lyell Immunopharma Inc. - Quantisnow

Nov 29, 2024
pulisher
Nov 29, 2024

Lyell Immunopharma Reports Resignation of Board Member - Defense World

Nov 29, 2024
pulisher
Nov 26, 2024

Lyell Immunopharma Director Hans bishop resigns - Investing.com

Nov 26, 2024
pulisher
Nov 26, 2024

Lyell Immunopharma Director Hans bishop resigns By Investing.com - Investing.com Australia

Nov 26, 2024
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):